Portal de Periódicos da CAPES

Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of Disease

2009; Elsevier BV; Volume: 175; Issue: 2 Linguagem: Inglês

10.2353/ajpath.2009.081011

1525-2191

Monica Bacci, Annalisa Capobianco, Antonella Monno, Lucia Cottone, Francesca Puppo, Barbara Camisa, Margherita Mariani, Chiara Brignole, Mirco Ponzoni, Stefano Ferrari, Paola Panina‐Bordignon, Angelo A. Manfredi, Patrizia Rovere-Querini,

Reproductive System and Pregnancy

The mechanisms that sustain endometrial tissues at ectopic sites in patients with endometriosis are poorly understood. Various leukocytes, including macrophages, infiltrate endometriotic lesions. In this study, we depleted mouse macrophages by means of either clodronate liposomes or monoclonal antibodies before the injection of syngeneic endometrial tissue. In the absence of macrophages, tissue fragments adhered and implanted into the peritoneal wall, but endometriotic lesions failed to organize and develop. When we depleted macrophages after the establishment of endometriotic lesions, blood vessels failed to reach the inner layers of the lesions, which stopped growing. Macrophages from patients with endometriosis and experimental mice, but not nonendometriotic patients who underwent surgery for uterine leiomyomas or control mice, expressed markers of alternative activation. These markers included high levels of scavenger receptors, CD163 and CD206, which are involved in both the scavenging of hemoglobin with iron transfer into macrophages and the silent clearance of inflammatory molecules. Macrophages in both inflammatory liquid and ectopic lesions were equally polarized, suggesting a critical role of environmental cues in the peritoneal cavity. Adoptively transferred, alternatively activated macrophages dramatically enhanced endometriotic lesion growth in mice. Inflammatory macrophages effectively protected mice from endometriosis. Therefore, endogenous macrophages involved in tissue remodeling appear as players in the natural history of endometriosis, required for effective vascularization and ectopic lesion growth. The mechanisms that sustain endometrial tissues at ectopic sites in patients with endometriosis are poorly understood. Various leukocytes, including macrophages, infiltrate endometriotic lesions. In this study, we depleted mouse macrophages by means of either clodronate liposomes or monoclonal antibodies before the injection of syngeneic endometrial tissue. In the absence of macrophages, tissue fragments adhered and implanted into the peritoneal wall, but endometriotic lesions failed to organize and develop. When we depleted macrophages after the establishment of endometriotic lesions, blood vessels failed to reach the inner layers of the lesions, which stopped growing. Macrophages from patients with endometriosis and experimental mice, but not nonendometriotic patients who underwent surgery for uterine leiomyomas or control mice, expressed markers of alternative activation. These markers included high levels of scavenger receptors, CD163 and CD206, which are involved in both the scavenging of hemoglobin with iron transfer into macrophages and the silent clearance of inflammatory molecules. Macrophages in both inflammatory liquid and ectopic lesions were equally polarized, suggesting a critical role of environmental cues in the peritoneal cavity. Adoptively transferred, alternatively activated macrophages dramatically enhanced endometriotic lesion growth in mice. Inflammatory macrophages effectively protected mice from endometriosis. Therefore, endogenous macrophages involved in tissue remodeling appear as players in the natural history of endometriosis, required for effective vascularization and ectopic lesion growth. Endometriosis is a common disease, characterized by the persistence and growth of vascularized endometrial tissue at ectopic sites, typically the pelvis, and associated with pelvic pain and infertility.1Lebovic DI Mueller MD Taylor RN Immunobiology of endometriosis.Fertil Steril. 2001; 75: 1-10Abstract Full Text Full Text PDF PubMed Scopus (675) Google Scholar, 2Giudice LC Kao LC Endometriosis.Lancet. 2004; 364: 1789-1799Abstract Full Text Full Text PDF PubMed Scopus (2496) Google Scholar, 3Berkley KJ Rapkin AJ Papka RE The pains of endometriosis.Science. 2005; 308: 1587-1589Crossref PubMed Scopus (338) Google Scholar Endometriotic lesions possibly originate from shed endometrial tissue that reaches the abdominal cavity via the Fallopian tubes during menstruation.4Sampson J Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity.Am J Obstet Gynecol. 1927; 14: 422-469Abstract Full Text PDF Google Scholar This process, referred to as retrograde menstruation, occurs in most women during the fertile years. In women who develop endometriosis, endometrial tissue attaches to the peritoneal wall. The following steps include invasion of the underlying basement membrane and recruitment of novel vessels from the peritoneal vasculature.5Dunselman GA Groothuis PG Etiology of endometriosis: hypotheses and facts.Gynecol Obstet Invest. 2004; 57: 42-43PubMed Google Scholar, 6Becker CM D'Amato RJ Angiogenesis and antiangiogenic therapy in endometriosis.Microvasc Res. 2007; 74: 121-130Crossref PubMed Scopus (98) Google Scholar The events underlying the susceptibility of menstruating women to endometriosis are obscure. The ability of shed endometrium, to attach and to infiltrate the peritoneum, to survive, and to recruit vessels are possibly limiting steps. Neo-angiogenesis physiologically takes place during wound healing as a consequence of macrophage activation.7van Amerongen MJ Harmsen MC van Rooijen N Petersen AH van Luyn MJ Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice.Am J Pathol. 2007; 170: 818-829Abstract Full Text Full Text PDF PubMed Scopus (396) Google Scholar, 8Martinez FO Sica A Mantovani A Locati M Macrophage activation and polarization.Front Biosci. 2008; 13: 453-461Crossref PubMed Scopus (2233) Google Scholar Macrophages represent a major source of neo-angiogenic signals in solid tumors, which depend on newly formed vessels for their growth and spreading. In solid tumors, macrophages also deliver signals that limit apoptosis under hypoxic conditions and facilitate local infiltration and metastatic spreading.9Allavena P Sica A Solinas G Porta C Mantovani A The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.Crit Rev Oncol Hematol. 2008; 66: 1-9Abstract Full Text Full Text PDF PubMed Scopus (750) Google Scholar Recombinant cytokines or microbial products elicit the in vitro differentiation of macrophage precursors toward such a reparative phenotype (also called alternative or M2 activation) or toward inflammatory M1 cells, better suited to fight invading pathogens. The signals that commit precursors in living tissues to polarize toward M1 or M2 macrophages, in conditions of infection, sterile injury, or neoplastic transformation, are only beginning to be elucidated. Interestingly, a heterogeneity in response to innate signals among the population has been demonstrated, suggesting that environmental signals result in diverse patterns of macrophage activation in different subjects.10Ferwerda B McCall MB Alonso S Giamarellos-Bourboulis EJ Mouktaroudi M Izagirre N Syafruddin D Kibiki G Cristea T Hijmans A Hamann L Israel S ElGhazali G Troye-Blomberg M Kumpf O Maiga B Dolo A Doumbo O Hermsen CC Stalenhoef AF van Crevel R Brunner HG Oh DY Schumann RR de la Rua C Sauerwein R Kullberg BJ van der Ven AJ van der Meer JW Netea MG TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans.Proc Natl Acad Sci USA. 2007; 104: 16645-16650Crossref PubMed Scopus (266) Google Scholar, 11Ferwerda B McCall MB Verheijen K Kullberg BJ van der Ven AJ Van der Meer JW Netea MG Functional consequences of toll-like receptor 4 polymorphisms.Mol Med. 2008; 14: 346-352Crossref PubMed Scopus (196) Google Scholar Differences in macrophage activation in the peritoneal cavity could therefore be involved in the susceptibility/resistance to endometriosis: a “permissive” macrophage activation would facilitate the survival of shed endometrial tissue via the production of trophic and anti-apoptotic signals, facilitate invasion of the mesothelial layer via interference with the balance between metalloproteinase and their inhibitors,12Wu MH Shoji Y Wu MC Chuang PC Lin CC Huang MF Tsai SJ Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis.Am J Pathol. 2005; 167: 1061-1069Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar and could be later on required for neo-angiogenesis. In the current study, using an experimental mouse model, we verified the hypothesis that macrophage activation is involved in the establishment, survival, and spreading of ectopic lesions from shed endometrium. We finely characterized macrophages in the peritoneal fluid and in established endometriotic lesions, in experimental mice and human, and found that they share evident features of alternative, disease-permissive, activation. All procedures were performed in the animal facility of H San Raffaele Scientific Institute (Italy) in accordance with European Union guidelines and with the approval of the Institutional Animal Care and Use Committee of our Institution. Eight-week-old female Balb/C mice were purchased from Charles River (Calco, Italy). We used 10 animals per experimental group for each independent experiment. Mice were initially treated subcutaneously with estradiol benzoate (3 μg/mouse, Intervet s.r.l., Milan, Italy). Seven days later mice were sacrificed (one donor mouse for every two to be challenged with endometrium), uteri were removed, seeded in a Petri dish containing warmed saline, and split longitudinally with a pair of scissors. Each uterine horn was identically processed, including isolation of endometrial tissue and its careful mechanical disruption in small cell aggregate suspension, of a maximal diameter that was consistently lower than 1 mm, before intraperitoneal injection of an experimental/control mice pair.13Somigliana E Vigano P Rossi G Carinelli S Vignali M Panina-Bordignon P Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis.Hum Reprod. 1999; 14: 2944-2950Crossref PubMed Scopus (167) Google Scholar, 14Somigliana E Vigano P Filardo P Candiani M Vignali M Panina-Bordignon P Use of knockout transgenic mice in the study of endometriosis: insights from mice lacking beta(2)-microglobulin and interleukin-12p40.Fertil Steril. 2001; 75: 203-206Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar By this approach each mouse received the suspension derived from a half uterus. Twelve days after endometrial tissue injection, mice were euthanized individually by cervical dislocation. The abdominal cavity was immediately opened and lesions excised and processed for disease assessment or immunohistochemistry evaluation. The extent of endometriosis was evaluated by assessing the dry weight of all lesions from each mice, as described.13Somigliana E Vigano P Rossi G Carinelli S Vignali M Panina-Bordignon P Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis.Hum Reprod. 1999; 14: 2944-2950Crossref PubMed Scopus (167) Google Scholar, 14Somigliana E Vigano P Filardo P Candiani M Vignali M Panina-Bordignon P Use of knockout transgenic mice in the study of endometriosis: insights from mice lacking beta(2)-microglobulin and interleukin-12p40.Fertil Steril. 2001; 75: 203-206Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar To verify the role of macrophages in the establishment and growth of ectopic endometrial lesions, mice were treated i.p. with the depleting anti-F4/80 Ab (0.80 μg/g/mice clone CI: A3-1, SeroTec, Oxford, UK) or PBS, or with liposomes containing either clodronate (Sigma Aldrich, St Louis, MO) or PBS, prepared as described.15Brignole C Pastorino F Marimpietri D Pagnan G Pistorio A Allen TM Pistoia V Ponzoni M Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.J Natl Cancer Inst. 2004; 96: 1171-1180Crossref PubMed Scopus (60) Google Scholar When indicated, depleting agents were injected intraperitoneally. The anti-F4/80 depleting mAb was injected at day −2, the treatment was repeated at day 0, +2, +4, +6, +8, +10 after uterus transfer. Liposomes containing PBS or clodronate were injected at days −1, 0, +4, and + 8 after endometrial tissue transfer. The final clodronate liposome suspension contained 5 mg of clodronate/ml. Both treatments kill monocytes and macrophages, while are not per se otherwise toxic. Control mice were injected i.p. with PBS. To assess the effect of macrophage depletion on ectopic endometrial tissue early survival and adhesion to the peritoneal cavity, depletion was performed only at day 0. To assess the effect of macrophage depletion on already established lesions, the treatment was performed exclusively at days + 4, +8, ie, after lesion engraftment. To verify the efficacy of the treatment, blood or peritoneal fluid was retrieved at various times and analyzed by flow cytometry. Samples (30 μl) were incubated for 10 minutes at room temperature with PBS containing 10% fetal calf serum. Phycoerythrin-conjugated anti-F4/80 mAb (clone CI: A3-1, SeroTec) and/or allophycocyanin-conjugated anti-CD11b mAb (clone M1/70, BD Biosciences) (2 μl/sample) were added for 20 minutes. Red blood cell lysis buffer (0.15 M/L NH4Cl, 1 mmol/L KHCO3, and 0.1 mmol/L Na2EDTA) was added for 10 minutes at room temperature before analysis (FACS Calibur flow cytometer and CellQuest software, BD Biosciences). Bone marrow precursors from Balb/C female mice were retrieved and cultured for 7 days in α-MEM (GIBCO, Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (Lonza, Basel, Switzerland) and recombinant murine (rm) macrophage-colony-stimulating factor (100 ng/ml), yielding non polarized macrophages (M0). Cells were then further cultured for 48 hours in the presence of rm interferon-γ (50 ng/ml) (PeproTech, Rocky Hill, NJ) to obtain inflammatory/M1 macrophages or with rm macrophage-colony-stimulating factor (10 ng/ml) + rm interleukin (IL)-10 (10 ng/ml) for 96 hours to obtain alternatively activated M2 cells. Polarization was verified by flow cytometry as described.16Lolmede K Campana L Vezzoli M Bosurgi L Tonlorenzi R Clementi E Bianchi ME Cossu G Manfredi AA Brunelli S Rovere-Querini P Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways.J Leukoc Biol. 2009; 85: 779-787Crossref PubMed Scopus (173) Google Scholar The secretion of prototypical M1 and M2 cytokines, such as tumor necrosis factor (TNF)-α and IL-10 respectively, was verified by enzyme-linked immunosorbent assay (R&D Systems). In selected experiments undifferentiated (M0), M1, and M2 macrophages generated in vitro as above, were injected in the peritoneal cavity of recipients mice at days −2, 0, and +2. At day 0, mice received the intraperitoneal injection of endometrial tissue and were sacrificed at day +12. Lesions were excised and processed for disease assessment or immunohistochemistry evaluation as above. Peritoneal cells were retrieved by peritoneal lavage of treated and untreated animals, and resuspended in cold PBS containing 2 mmol/L EDTA. Cell viability, verified by trypan blue exclusion, was typically >98%. Cells were stained with allophycocyanin-conjugated anti-CD11b Ab (BD, Pharmingen), phycoerythrin-conjugated anti-F4-80 Ab (R&D), or with purified unlabeled rat anti-mouse anti-CD206 Ab and purified antibody rabbit anti-mouse anti-CD163 (Serotec). Phycoerythrin-conjugated goat anti-rat or fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit Ab were used as second step reagents before analysis by 2- and 4-parametric flow cytometry. Endometriotic lesions were frozen in liquid N2-cooled isopentane. Serial 6-mm thick sections were fixed with 4% paraformaldehyde (10 minutes at room temperature) and successively treated with 0.3% H2O2 (10 minutes at room temperature) to quench endogenous peroxidase activity. To evaluate macrophage infiltration, tissue sections were incubated in PBS + 5% bovine serum albumin for 1 hour at room temperature and then overnight at 4°C with rat anti-mouse CD68 mAb (2 mg/ml, clone FA-11, SeroTec), CD163 (1 mg/ml, clone M-96, Santa Cruz Biotechnology, Inc, Santa Cruz, CA), and CD206 (1 mg/ml, clone MR5D3, SeroTec). Endothelial cells were identified by staining with anti-mouse CD31 mAb (Serotec). Primary Abs were revealed using biotin conjugated anti-rat polyclonal IgG (1.5 mg/ml, eBiosciences, San Diego, CA) and R.T.U horseradish peroxidase streptavidin (Vector Laboratories, Burlingame, CA), which was detected using Vector NovaRED substrate kit (Vector Laboratories). Slides were counterstained with hematoxylin and examined under a Nikon Eclipse 55i microscope (Nikon, Tokyo, Japan). Images were captured with Digital Sight DS-5 M digital camera (Nikon) using Lucia G software (Laboratory Imaging, Prague, CZ). Parallel slides in which primary Abs had been omitted were identically processed and used as negative controls. Venous blood, peritoneal liquid, and tissue samples (lesions and disease-free peritoneum) were obtained between September 2006 and June 2007 from 23 patients with pathologically proven endometriosis and 13 matched controls undergoing surgery for uterine leyiomyomas, all followed in the Department of Obstetrics & Gynaecology of the H San Raffaele Scientific Institute (Italy). The San Raffaele Ethical Committee approved the study protocol and all subjects provided written informed consent. Patients and controls were menstruating women between 20 and 45 years that did not receive hormonal and/or anti-inflammatory medications for at least 3 months before sample collection. The stage of disease was established according to the revised American Fertility Society (AFSr) classification.17Revised American Fertility Society classification of endometriosis: 1985.Fertil Steril. 1985; 43: 351-352Abstract Full Text PDF PubMed Google Scholar In our analysis, we considered three stages, mild (AFSr stages I–II; n = 5), moderate (AFSr stage III; n = 8), and severe (AFSr stage IV; n = 8). Peripheral blood mononuclear cells were obtained by centrifugation over a ficoll density gradient (Ge Health Care, Piscataway NJ) and inflammatory cells within the peritoneal fluid were obtained by centrifugation after lysis of red blood cells with ammonium chloride (0.15 M/L NH4Cl, 1 mmol/L KHCO3, 0.1 mmol/L Na2EDTA). Viable cells, identified by trypan blue exclusion, were consistently >90%. 1 to 1.5 × 105 cells/sample were stained with: Percp-conjugated anti-CD45 and anti-CD14, phycoerythrin-conjugated anti-CD16, and anti-CD163, FITC-conjugated anti-CD206 anti-CD36, anti-CD86, anti-HLA-ABC, anti-HLA-DR mAbs, all from Becton Dickinson (BD Pharmingen, California). When indicated, cells were stained with purified anti-receptor for advanced glycation end products (rabbit polyclonal IgG, Santa Cruz Biotecnology) or with biotinylated anti-αVβ3 mAbs (Chemicon International). FITC-conjugated anti-rabbit Ab or FITC-conjugated streptavidin were used as second step reagents. Cells were analyzed by flow cytometry (FACS Calibur, Bekton Dickinson California). Analysis was performed using a FACS express version 3 software. Samples were immediately frozen in optimal cutting temperature compound at −80°C. Five- to six-micron thick sections were fixed with 4% paraformaldehyde for 10 minutes at room temperature, before staining with purified mouse anti-human-CD68, anti-CD163 (Dako), anti-CD206 (BD Pharmingen) overnight at room temperature. Biotinylated rat-anti-mouse antibodies were used as second-step reagents. Samples were then processed as described18Akoum A Jolicoeur C Kharfi A Aube M Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis.Am J Pathol. 2001; 158: 481-489Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar and examined under a Nikon Eclipse 55i microscope (Nikon, Tokyo, Japan). Images were captured with Digital Sight DS-5 M digital camera (Nikon) using Lucia G software (Laboratory Imaging, Prague, CZ). Parallel slides in which primary Ab had been omitted were identically processed and used as negative controls. Infiltration score was calculated independently by two blinded investigators, using grades from 1 to 4: 1, no infiltrating macrophages expressing the given marker; 2, sparse infiltrates, ≤5 infiltrating macrophages expressing the given marker per 0.6-mm lesion core; 3, moderate infiltrates, for >5 but ≤25 infiltrating macrophages expressing the given marker per 0.6-mm lesion core, and 4, dense infiltrates, for >25 infiltrating macrophages expressing the given marker per 0.6-mm lesion core. Statistical analysis was performed using bivariate correlation and linear regression analysis for continuous variable and two-tailed Student’s t-test for unpaired samples with unequal variance to analyze differences between groups. Analysis was performed with SPSS (11.0 Mac OS × Version). We compared the establishment of ectopic endometrial lesions in Balb/C mice treated with macrophage-depleting liposomes containing clodronate or with control sham liposomes containing PBS. To minimize the risk of artifacts, mice cohorts were divided in pairs (control and experimental), each receiving identical amounts of endometrial cell suspension from a single syngeneic donor (Figure 1, A). At sacrifice, 12 days after intraperitoneal injection of syngeneic endometrial tissue, lesions had developed in all mice. Depletion was effective, since the fraction of F4/80+ and CD11b+ macrophages abated in the peritoneal cavity of mice treated with liposomes containing clodronate, but not in those treated with liposomes containing PBS (Figure 1B). Endometriotic lesions from macrophage-depleted mice were significantly smaller as reflected by their total weight (Figure 1C). To verify that the result of the treatment was due to macrophage depletion, we injected animals 48 hours before intraperitoneal injection of endometrial tissue with a different macrophage-depleting agent, ie, the F4/80 mAb. mAb injection was then repeated every 48 hours (Figure 1D). Significantly smaller ectopic lesions developed in mice treated with macrophage-depleting mAb than in animals injected with PBS (Figure 1, E–F). We then assessed whether macrophages were required for the implant of endometrial tissue on the peritoneal membrane and for the ensuing growth of established ectopic lesions. We depleted macrophages with liposomes containing clodronate 24 hours before injection of endometrial tissue (Figure 2A). Peritoneal F4/80+ and CD11b+ macrophages had returned to almost normal levels at the time of sacrifice (day 12), indicating that the effect of the treatment was indeed transient (Figure 2D). Lesions number, weight and microscopic architecture were not apparently affected in depleted animals (Figure 2C). We also injected syngeneic endometrium at day 0 and treated mice with liposomes containing clodronate or PBS at days 4 and 8 (Figure 2B). Only small numbers of F4/80+ and CD11b+ macrophages were detectable in the peritoneal fluid at day 12, when animals were sacrificed, indicating that the depletion was maintained (Figure 2F). The number of the implanted endometriotic lesions did not differ in treated animals (4.83 ± 0.3/mouse and 3.33 ± 0.71/mouse in control and macrophage-depleted animals respectively), but the total weight of the lesions was significantly lower (Figure 2E). At the microscopic levels, lesions in control mice consisted of dilated glands with columnar or cuboid epithelial endometrial cells, surrounded by narrow stroma layers, with newly formed vessels characterized by CD31+ endothelial cells (Figure 2G). CD68+ macrophages infiltrated endometriotic lesions (Figure 2G). In contrast, in macrophage-depleted animals, the glandular and stromal architecture was disrupted (Figure 2G), with severely reduced vascularization, as assessed by staining of endothelia with the anti-CD31 mAb (Figure 2, G and H). We derived and analyzed by flow cytometry peritoneal macrophages from control and endometriotic mice. The fraction of peritoneal CD11b+ macrophages did not differ in the two groups of mice. In mice with endometriosis, we observed a substantial and significant increase in the fraction of peritoneal macrophages that expressed the F4/80 antigen (96.35 ± 0.6% of CD11b+ cells; P = 0.002 vs controls). CD11b+ macrophages from the peritoneal liquid of endometriotic mice co-expressed markers of alternative activation, the hemoglobin scavenger receptor, CD163 and the mannose receptor, CD206, which were virtually absent in CD11b+ macrophages of control mice (58.41 ± 8.4 of CD163+, 56.8 ± 13.8 of CD206+ cells; P = 0.01 and 0.03 respectively versus controls) (Figure 3, A and B). CD68+ macrophages infiltrating endometriotic lesions expressed the CD163 and the CD206 receptors (Figure 3B), while those associated to the peritoneal tissue of control mice were next to negative (not shown). To verify the relevance of the results obtained in the mouse model for the human disease, we analyzed peritoneal cells and tissues from 21 consecutive endometriotic patients and 12 matched controls. To unambiguously identify macrophages in the peritoneal fluid, flow cytometric analysis has been performed on the cluster depicted in Figure 4A, in which events with congruent side scatter physical characteristics were selected among cells expressing the CD45 common leukocyte antigen. Cells were then analyzed for the expression of lineage and activation markers, as depicted in Figure 4A for the CD14 receptor. While CD14+ peritoneal macrophages were similar in patients and controls, CD16+ cells were 50.04 ± 8.6 of macrophages in endometriotic patients and 5.68 ± 3.2 in control subjects (P < 0.01); macrophages expressing the CD163 hemoglobin scavenger receptor were 19.04 ± 5.4 in patients and 1.75 ± 0.56 in controls (P < 0.01); macrophages expressing the CD206 mannose receptor were 68.82 ± 5.6 in patients and 33.68 ± 7.6 in controls (P < 0.01) (Figure 4B). The fraction of peritoneal macrophages from endometriotic patients and control subjects that express the CD86 receptor (Figure 4B) or the MHC class I and II, αvβ3, CD40, and CD36 molecules was similar (not shown), while the difference in the fraction of anti-receptor for advanced glycation end products-expressing macrophages, although significant, was modest (Figure 4B). The level of expression of each molecule, as assessed by the associated relative fluorescence intensity, was similar in CD14+ peritoneal macrophages from patients and controls, with the exception of CD16, whose expression was significantly higher in patients (relative fluorescence intensity was 6.89 ± 2.3 in patients and 2.37 ± 0.66 in controls, P < 0.05; Figure 4C). The differences were specifically associated to the peritoneal environment, because we failed to detect any significant difference between the expression of these markers in circulating leukocytes from patients and controls (not shown). We did not observe any correlation between the expression of markers of macrophage alternative activation and the clinical stage of the disease.19Revised American Society for Reproductive Medicine classification of endometriosis: 1996.Fertil Steril. 1997; 67: 817-821Abstract Full Text PDF PubMed Scopus (2260) Google Scholar However, only five patients with mild endometriosis (stages I–II) were studied. Data on a larger cohort of patients will be necessary to draw conclusions on the influence of endometriosis stage on this parameter. The immunohistochemical study confirmed that CD68+ macrophages preferentially infiltrate endometriotic lesions, even if they can be detected also in the disease-free peritoneum of patients and controls and in uterine leiomyomas. Endometriotic macrophages only expressed the CD163 and CD206 receptors, which were virtually absent in control tissues (Figure 5A). The difference was statistically significant (P < 0.05; Figure 5B). To directly address the role of macrophage activation and polarization in vivo we propagated from syngeneic bone marrow precursors either undifferentiated M0 macrophages or cells polarized toward an M1 inflammatory or M2 alternatively activated macrophages (Figure 6A). M0 cells did not secrete significant amounts of cytokines. In contrast M1 macrophages produced significant amounts of TNF-α and negligible amount of IL-10. The opposite was true for M2 macrophages, which secreted IL-10 but not TNF-α (Figure 6B). M0, M1, and M2 macrophages were transferred in the peritoneum of recipient mice 2 days before and at the time of the injection of endometrium. Macrophage transfer was repeated 2 days after. Non differentiated M0 macrophages did not influence the establishment and the growth of endometrial lesions, as assessed at the time of animal sacrifice. In contrast lesions growth was significantly reduced in the presence of M1 macrophages (Figure 6C) and significantly enhanced in the presence of M2 macrophages (Figure 6C). Lesions in mice injected with M1 macrophages were barely detectable and exhibited a severely disrupted architecture (Figure 6D). Macrophages play a critical role, via their ability to guide tissue regeneration, in the growth of tumors and in diseases characterized by persistent tissue remodeling.9Allavena P Sica A Solinas G Porta C Mantovani A The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.Crit Rev Oncol Hematol. 2008; 66: 1-9Abstract Full Text Full Text PDF PubMed Scopus (750) Google Scholar, 20Brunelli S Rovere-Querini P The immune system and the repair of skeletal muscle.Pharmacol Res. 2008; 58: 117-121Crossref PubMed Scopus (95) Google Scholar, 21MacKinnon AC Farnworth SL Hodkinson PS Henderson NC Atkinson KM Leffler H Nilsson UJ Hasle